Accenture’s Stock Bounced—But Is It Really a Buy After Wall Street’s Downgrades?

(SeaPRwire) –

By: Christian Pierce

Accenture’s stock popped 1.65% last Friday. It ended a five-day losing streak. But it’s still 46% below its 52-week peak of $317.31. Multiple Wall Street firms have slashed their price targets on the stock. Retail and institutional investors alike are wondering if this is a buying opportunity.

Trading volume hit 4 million shares on Friday, below the 50-day average of 5.4 million. Institutional investors hold 75.14% of all ACN stock. Vontobel Holding lifted its stake by 36.8% in Q4. Vanguard added 854,361 shares in the same quarter. Massachusetts Financial Services lifted its holding by 5.4%. CEO Atsushi Egawa sold 4,872 shares in late April under a pre-arranged 10b5-1 plan. That cut his ownership stake by 27.57%. Truist downgraded ACN from Buy to Hold, slashing its target price to $210. Wells Fargo, Morgan Stanley, RBC and BMO also trimmed their targets. The 27 analysts covering the stock still have a Moderate Buy consensus, with an average target of $259.89. Accenture beat Q3 earnings estimates, posting $2.93 EPS on $18.04 billion in revenue. It pays a 3.8% annual dividend, with a 53.4% payout ratio. Full-year EPS forecasts sit at $13.87. The company has a market cap of around $113 billion and a 12-month low of $155.82. The stock trades below both its 50-day and 200-day moving averages of $181.79 and $221.83 respectively.

The insider sale, even under a pre-planned program, signals some leadership caution. The big institutional buys suggest long-term confidence in the firm’s consulting business. The weak Friday volume shows most investors aren’t ready to commit fully yet. For most investors, the best call is to hold off on a full position, but add small shares if the price dips back toward the 12-month low of $155.82.

Author bio: Christian Pierce, a chief financial columnist and markets commentator with 15 years covering global enterprise stock trends.